Although these biochemical and morphological approaches do not suggest major alterations in δ-cell mass and somatostatin stores, further studies are needed to determine whether altered somatostatin secretion plays a significant (paracrine) role in the dysfunction of α- and β-cells in type-2 diabetes. This evidence concerns the gene SST and type 2 diabetes mellitus.